{"filing":{"accession_number":"0001493152-26-031917","cik":"0001938046","ticker":"MGRX","company_name":"MANGOCEUTICALS, INC.","form":"8-K","filing_date":"2026-07-02","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315226031917/form8-k.htm"},"events":[{"id":15898,"run_id":14177,"accession_number":"0001493152-26-031917","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses an unregistered private placement of 850,000 shares of restricted common stock at $0.32 per share for $272,000 to an accredited investor, claimed under Section 4(a)(2) and Rule 506 of Regulation D. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure, particularly for a small-cap emerging growth company like Mangoceuticals.","company_name":"MANGOCEUTICALS, INC.","ticker":"MGRX","filing_date":"2026-07-02","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":13819,"accession_number":"0001493152-26-031917","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses an unregistered private placement of 850,000 shares of restricted common stock at $0.32 per share for $272,000 to an accredited investor, claimed under Section 4(a)(2) and Rule 506 of Regulation D. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure, particularly for a small-cap emerging growth company like Mangoceuticals.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:33:13.640877+00:00","company_name":"MANGOCEUTICALS, INC.","ticker":"MGRX","filing_date":"2026-07-02"}]}